Cytosorbents Corp
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Princeton, NJ
CTSO chart
What traders are saying about $CTSO
Latest postsCytosorbents Corp news
- Cytosorbents Corporation Estimates – NASDAQ:CTSO
TradingView ·
- What Is Powering the Rally in Karyopharm Therapeutics, Estrella Immunopharma, CytoSorbents, MoonLake Immunotherapeutics, FibroBiologics, Exicure, Biohaven and Profusa Stocks Today, and What Should Investors Know About the Catalysts?
kalkine.ca ·
- WBB Securities initiates coverage of CytoSorbents with Speculative Buy rating, $9.50 price target
TradingView ·
- WBB Securities Initiates Cytosorbents(CTSO.US) With Buy Rating, Announces Target Price $9.5
Moomoo ·
- WBB Securities initiates CytoSorbents stock with Speculative Buy By Investing.com
Investing.com South Africa ·
- WBB Securities initiates CytoSorbents stock with Speculative Buy
Investing.com ·
- CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care
Yahoo Finance ·
- CytoSorbents Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance ·
- CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Yahoo Finance ·
- CytoSorbents Announces Reverse Stock Split
Yahoo Finance ·
- CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor
Yahoo Finance ·
Cytosorbents Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$8.2M | -$20.7M | -$29.2M | -$32.8M |
| Diluted EPS | $-0.13 | $-0.38 | $-0.65 | $-0.75 |
| Total assets (year end) | $44.2M | $47.4M | $53.0M | $63.2M |
| Cash and equivalents (year end) | $6.2M | $3.3M | $14.1M | $22.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cytosorbents Corp
- Ticker
- CTSO (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1175151
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
Frequently asked questions
What exchange is Cytosorbents Corp listed on?
Cytosorbents Corp trades on the Nasdaq under the ticker symbol CTSO.
What industry is Cytosorbents Corp in?
Cytosorbents Corp is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Cytosorbents Corp headquartered?
Cytosorbents Corp's business address on file with the SEC is in Princeton, NJ.
When does Cytosorbents Corp's fiscal year end?
Cytosorbents Corp's fiscal year ends on December 31.
How much revenue did Cytosorbents Corp report?
Cytosorbents Corp reported $22.5M in revenue for calendar year 2018, according to its SEC filings.